Shijiazhuang Changshan Textile Co Ltd (000158 SHE) stock market data APIs
¥19.79
0.1(0.5%)
as of January 17, 2025
Shijiazhuang Changshan Textile Co Ltd Financial Data Overview
Price chart is built with
Anychart
Shijiazhuang ChangShan BeiMing Technology Co.,Ltd manufactures and sells textile products in China. The company offers yarns, fabrics, clothing, home textiles, and industrial textiles. It also operates a cloud data center; provides consulting, implementation, operation, and maintenance services for smart cities; and operates an online dispute resolution platform. The company was formerly known as Shijiazhuang Changshan Textile Company Limited and changed its name to Shijiazhuang ChangShan BeiMing Technology Co.,Ltd in October 2017. Shijiazhuang ChangShan BeiMing Technology Co.,Ltd was founded in 1998 and is based in Shijiazhuang, China.
Prev. Close
19.69
Open
19.79
Volume
81 485 K
High
20.18
Low
19.62
52 wk Range
5.4-39.88
Market Cap
31 477 M
Shares Outstanding
1 599 M
Revenue
9 268 M
EPS
-0.0256
Beta
0.036
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Shijiazhuang Changshan Textile Co Ltd data using free add-ons & libraries
Get Shijiazhuang Changshan Textile Co Ltd Fundamental Data
Shijiazhuang Changshan Textile Co Ltd Fundamental data includes:
- Net Revenue: 9 268 M
- EBITDA: -6 959 707
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-09-30
- EPS/Forecast: NaN
Get Shijiazhuang Changshan Textile Co Ltd End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shijiazhuang Changshan Textile Co Ltd News
New
Oncopeptides enrolls the first patient in the phase 3 LIGHTHOUSE combination study in multiple myeloma
STOCKHOLM, Dec. 21, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), today announced that the first patient has been dosed in the phase 3 LIGHTHOUSE study, evaluating the efficacy...
Oncopeptides enrolls the first patient in the phase 3 LIGHTHOUSE combination study in multiple myeloma
STOCKHOLM, Dec. 21, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), today announced that the first patient has been dosed in the phase 3 LIGHTHOUSE study, evaluating the efficacy...
Oncopeptides strengthens its organization by appointing Linda Holmström as Director of Investor Relations
STOCKHOLM, Dec. 15, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological ...
Oncopeptides strengthens its organization by appointing Linda Holmström as Director of Investor Relations
STOCKHOLM, Dec. 15, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
